Rating Reporting: Proteome Sciences PLC (LON:PRM) Stock Corporate Rating Reaffirmed at finnCap; The Target Price is Set to GBX 12.00

November 29, 2016 - By Ellis Scott

Proteome Sciences PLC (LON:PRM) Rating

finnCap have a GBX 12.00 TP on the stock. The TP would suggest a potential upside of 113.14% from Proteome Sciences PLC (LON:PRM)‘s stock close price. This rating was disclosed in a research note on Tuesday morning.

About 192,017 shares traded hands. Proteome Sciences plc (LON:PRM) has declined 70.63% since April 29, 2016 and is downtrending. It has underperformed by 75.88% the S&P500.

Proteome Sciences plc is a protein biomarker firm specializing in proteomics and peptidomics services and applications, and mass spectrometry protein analysis. The company has a market cap of 15.19 million GBP. The Firm is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It currently has negative earnings. It operates through the EU (the United Kingdom and Germany) and the United States geographic regions.

Another recent and important Proteome Sciences plc (LON:PRM) news was published by Uk.Finance.Yahoo.com which published an article titled: “Proteome Sciences plc (PRM.L)” on March 29, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News